newsfilter
← Latest News
GlobeNewswire·

Mesoblast Financial Results and Corporate Update Webcast

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and